http://medicalxpress.com/ en-us Medical Xpress internet news portal provides the latest news on Health and Medicine. High epidermal growth factor receptor (EGFR) expression was a good predictor of which lung cancer patients would survive longer when cetuximab (Erbitux) was added to first-line chemotherapy, according to research presented at the 14th World Conference on Lung Cancer in Amsterdam, hosted by the International Association for the Study of Lung Cancer (IASLC). http://medicalxpress.com/news/2011-07-high-egfr-predictor-survival-cetuximab.html Cancer Tue, 05 Jul 2011 04:51:10 EST news229060256